SIRT3 and lung carcinoma: demonstrated that SIRT3 rescues doxorubicin-induced senescence in A549 lung cancer cells by restoring autophagic flux and inhibiting the PI3K/AKT/mTOR pathway, implicating SIRT3 in the regulation of oxidative stress and anti-aging functions (119).